FEBRUARY 2008
Continuations rules promote the public interest
The USPTO's new rules on claims and continuations will overwhelmingly benefit the public interest and should be supported, argues Daniel Ravicher
As executive director of the Public Patent Foundation (PUBPAT), a not-for-profit legal services organization that represents the public interest in the patent system, I write in response to the interview with Sherry Knowles of GlaxoSmithKline (GSK) published in Managing IP's December/January issue. In particular, I wish to address Ms Knowles's comments on the lawsuit GSK filed against the USPTO and its recently passed rules relating to the filing by patent applicants of an unlimited number of continuation applications and an unlimited number of claims.
The rest of this article is available to subscribers only. Subscribe today for full access to this article.
Alternatively take a free trial, giving you access to the current issue's contents*
If you are already a subscriber, please log in below to access the rest of this article.
*excludes some surveys and articles.